학술논문
Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Document Type
article
Author
Eckardt, Kai-Uwe; Bansal, Nisha; Coresh, Josef; Evans, Marie; Grams, Morgan E; Herzog, Charles A; James, Matthew T; Heerspink, Hiddo JL; Pollock, Carol A; Stevens, Paul E; Tamura, Manjula Kurella; Tonelli, Marcello A; Wheeler, David C; Winkelmayer, Wolfgang C; Cheung, Michael; Hemmelgarn, Brenda R; Participants, Conference; Abu-Alfa, Ali K; Anand, Shuchi; Arici, Mustafa; Ballew, Shoshana H; Block, Geoffrey A; Burgos-Calderon, Rafael; Charytan, David M; Das-Gupta, Zofia; Dwyer, Jamie P; Fliser, Danilo; Froissart, Marc; Gill, John S; Griffith, Kathryn E; Harris, David C; Huffman, Kate; Inker, Lesley A; Jager, Kitty J; Jun, Min; Kalantar-Zadeh, Kamyar; Kasiske, Bertrand L; Kovesdy, Csaba P; Krane, Vera; Lamb, Edmund J; Lerma, Edgar V; Levey, Andrew S; Levin, Adeera; Mauro, Juan Carlos Julián; Nash, Danielle M; Navaneethan, Sankar D; O’Donoghue, Donal; Obrador, Gregorio T; Pecoits-Filho, Roberto; Robinson, Bruce M; Schäffner, Elke; Segev, Dorry L; Stengel, Bénédicte; Stenvinkel, Peter; Tangri, Navdeep; Tentori, Francesca; Tsukamoto, Yusuke; Turakhia, Mintu P; Vazquez, Miguel A; Wang, Angela Yee-Moon; Williams, Amy W
Source
Kidney International. 93(6)
Subject
Language
Abstract
Patients with severely decreased glomerular filtration rate (GFR) (i.e., chronic kidney disease [CKD] G4+) are at increased risk for kidney failure, cardiovascular disease (CVD) events (including heart failure), and death. However, little is known about the variability of outcomes and optimal therapeutic strategies, including initiation of kidney replacement therapy (KRT). Kidney Disease: Improving Global Outcomes (KDIGO) organized a Controversies Conference with an international expert group in December 2016 to address this gap in knowledge. In collaboration with the CKD Prognosis Consortium (CKD-PC) a global meta-analysis of cohort studies (n = 264,515 individuals with CKD G4+) was conducted to better understand the timing of clinical outcomes in patients with CKD G4+ and risk factors for different outcomes. The results confirmed the prognostic value of traditional CVD risk factors in individuals with severely decreased GFR, although the risk estimates vary for kidney and CVD outcomes. A 2- and 4-year model of the probability and timing of kidney failure requiring KRT was also developed. The implications of these findings for patient management were discussed in the context of published evidence under 4 key themes: management of CKD G4+, diagnostic and therapeutic challenges of heart failure, shared decision-making, and optimization of clinical trials in CKD G4+ patients. Participants concluded that variable prognosis of patients with advanced CKD mandates individualized, risk-based management, factoring in competing risks and patient preferences.